Chad Messer
Stock Analyst at Lake Street
(0.70)
# 4,093
Out of 5,149 analysts
29
Total ratings
23.33%
Success rate
-17.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Maintains: Buy | $22 → $32 | $21.54 | +48.56% | 2 | Dec 16, 2025 | |
| OSTX OS Therapies | Maintains: Buy | $18 → $17 | $1.40 | +1,114.29% | 2 | Nov 18, 2025 | |
| GNLX Genelux | Initiates: Buy | $16 | $2.58 | +520.16% | 1 | Oct 21, 2025 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $106 | $51.88 | +104.32% | 1 | Sep 23, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Buy | $4 → $75 | $4.44 | +1,589.19% | 2 | Aug 15, 2025 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $7 | $1.04 | +573.08% | 1 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Initiates: Buy | $16 | $4.69 | +241.15% | 1 | Jul 9, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $2.71 | +822.51% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $2.91 | +3,817.53% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $107.40 | -53.45% | 1 | Jul 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $48 | $60.72 | -20.95% | 2 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $30 | $40.74 | -26.36% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $6.91 | +319.68% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.41 | +2,339.02% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $78.66 | +9.33% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $15.81 | +178.30% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $15.87 | +946.00% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $1.22 | +1,375.41% | 1 | May 5, 2020 |
Immunome
Dec 16, 2025
Maintains: Buy
Price Target: $22 → $32
Current: $21.54
Upside: +48.56%
OS Therapies
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $17
Current: $1.40
Upside: +1,114.29%
Genelux
Oct 21, 2025
Initiates: Buy
Price Target: $16
Current: $2.58
Upside: +520.16%
Monopar Therapeutics
Sep 23, 2025
Initiates: Buy
Price Target: $106
Current: $51.88
Upside: +104.32%
Bolt Biotherapeutics
Aug 15, 2025
Maintains: Buy
Price Target: $4 → $75
Current: $4.44
Upside: +1,589.19%
Oncolytics Biotech
Aug 13, 2025
Initiates: Buy
Price Target: $7
Current: $1.04
Upside: +573.08%
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $4.69
Upside: +241.15%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $2.71
Upside: +822.51%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $2.91
Upside: +3,817.53%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $107.40
Upside: -53.45%
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $60.72
Upside: -20.95%
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $40.74
Upside: -26.36%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $6.91
Upside: +319.68%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $0.41
Upside: +2,339.02%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $78.66
Upside: +9.33%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $15.81
Upside: +178.30%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $15.87
Upside: +946.00%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $1.22
Upside: +1,375.41%